Latest Mergers And Acquisitions News

Calix Limited has successfully closed its Share Purchase Plan, raising $2.1 million to complement a prior $20 million institutional placement, strengthening its balance sheet to advance key environmental technology projects.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

Philsaga Mining Corporation has announced a delay in the completion of its Tigerway decline at the Co-O Mine, citing COVID-19 disruptions and a significant earthquake as key factors. The company is now focusing on horizontal drives to improve ore transport and ventilation, with full decline completion expected by year-end 2025.

Peregrine Gold Limited has successfully raised $1.74 million through its recent entitlement offer, securing key shareholder support to advance exploration at its Tin Can Trend project.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Savannah Goldfields Limited has announced a fully underwritten entitlement offer and placements to raise up to $9.91 million, aiming to fund a restart of mining and processing operations alongside debt repayments and exploration.

Savannah Goldfields Limited has announced a $9.91 million equity raising to fund the restart of mining operations and regional expansion in Far North Queensland. The company targets resuming production in H1 2025 with a focus on optimising costs amid a strong gold price environment.

Top End Energy has completed its acquisition of Serpentine Energy, securing a strategic natural hydrogen project in Kansas and gearing up for exploration drilling in the second half of 2025.

Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.

Bryah Resources has locked in $1.1 million through a two-tranche placement to fund its copper exploration efforts in the Bryah Basin and support ongoing business development.

Medallion Metals Limited has secured $6.5 million through a placement to support its strategic acquisition of Forrestania Nickel Operation assets and advance the Ravensthorpe Gold Project, positioning the company for a final investment decision by late 2025.